Literature DB >> 21540286

Highly visible expression of an oxytocin-monomeric red fluorescent protein 1 fusion gene in the hypothalamus and posterior pituitary of transgenic rats.

Akiko Katoh1, Hiroaki Fujihara, Toyoaki Ohbuchi, Tatsushi Onaka, Takashi Hashimoto, Mitsuhiro Kawata, Hideaki Suzuki, Yoichi Ueta.   

Abstract

We have generated rats bearing an oxytocin (OXT)-monomeric red fluorescent protein 1 (mRFP1) fusion transgene. The mRFP1 fluorescence was highly visible in ventral part of the supraoptic nucleus (SON) and the posterior pituitary in a whole mount. mRFP1 fluorescence in hypothalamic sections was also observed in the SON, the paraventricular nucleus (PVN), and the internal layer of the median eminence. Salt loading for 5 d caused a marked increase in mRFP1 fluorescence in the SON, the PVN, the median eminence, and the posterior pituitary. In situ hybridization histochemistry revealed that the expression of the mRNA encoding the OXT-mRFP1 fusion gene was observed in the SON and the PVN of euhydrated rats and increased dramatically after chronic salt loading. The expression of the endogenous OXT and the arginine vasopressin (AVP) genes were significantly increased in the SON and the PVN after chronic salt loading in both nontransgenic and transgenic rats. These responses were not different between male and female rats. Compared with nontransgenic rats, euhydrated and salt-loaded male and female transgenic rats showed no significant differences in plasma osmolality, sodium concentration, OXT, and AVP levels. Finally, we succeeded in generating a double-transgenic rat that expresses both the OXT-mRFP1 fusion gene and the AVP-enhanced green fluorescent protein fusion gene. Our new transgenic rats are valuable new tools to study the physiology of the hypothalamo-neurohypophysial system.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21540286     DOI: 10.1210/en.2011-0006

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  25 in total

1.  Glial control of endocannabinoid heterosynaptic modulation in hypothalamic magnocellular neuroendocrine cells.

Authors:  Shi Di; Ion R Popescu; Jeffrey G Tasker
Journal:  J Neurosci       Date:  2013-11-13       Impact factor: 6.167

2.  Possible involvement of central oxytocin in cisplatin-induced anorexia in rats.

Authors:  Koichi Arase; Hirofumi Hashimoto; Satomi Sonoda; Hiromichi Ueno; Reiko Saito; Yasuhito Motojima; Mitsuhiro Yoshimura; Takashi Maruyama; Keiji Hirata; Yasuhito Uezono; Yoichi Ueta
Journal:  J Physiol Sci       Date:  2017-06-14       Impact factor: 2.781

Review 3.  Modulation/physiology of calcium channel sub-types in neurosecretory terminals.

Authors:  José R Lemos; Sonia I Ortiz-Miranda; Adolfo E Cuadra; Cristina Velázquez-Marrero; Edward E Custer; Taimur Dad; Govindan Dayanithi
Journal:  Cell Calcium       Date:  2012-02-17       Impact factor: 6.817

Review 4.  Electrophysiological properties of identified oxytocin and vasopressin neurones.

Authors:  William E Armstrong; Robert C Foehring; Matthew K Kirchner; Celia D Sladek
Journal:  J Neuroendocrinol       Date:  2019-02-14       Impact factor: 3.627

5.  High Salt Intake Recruits Tonic Activation of NR2D Subunit-Containing Extrasynaptic NMDARs in Vasopressin Neurons.

Authors:  Chiranjivi Neupane; Ramesh Sharma; Yoon Hyung Pai; So Yeong Lee; Byeong Hwa Jeon; Hyun-Woo Kim; Javier E Stern; Jin Bong Park
Journal:  J Neurosci       Date:  2020-12-10       Impact factor: 6.167

Review 6.  The role of oxytocin in shaping complex social behaviours: possible interactions with other neuromodulators.

Authors:  Pietro Paletta; Noah Bass; Martin Kavaliers; Elena Choleris
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2022-07-11       Impact factor: 6.671

Review 7.  Oxytocin as a potential pharmacological tool to combat obesity.

Authors:  Pawel K Olszewski; Emily E Noble; Luis Paiva; Yoichi Ueta; James E Blevins
Journal:  J Neuroendocrinol       Date:  2022-02-22       Impact factor: 3.870

Review 8.  Oxytocin: a therapeutic target for mental disorders.

Authors:  Mitsuhiro Matsuzaki; Hiroaki Matsushita; Kazuhito Tomizawa; Hideki Matsui
Journal:  J Physiol Sci       Date:  2012-09-25       Impact factor: 2.781

Review 9.  The hypothalamic-neurohypophyseal system: from genome to physiology.

Authors:  D Murphy; A Konopacka; C Hindmarch; J F R Paton; J V Sweedler; M U Gillette; Y Ueta; V Grinevich; M Lozic; N Japundzic-Zigon
Journal:  J Neuroendocrinol       Date:  2012-04       Impact factor: 3.627

Review 10.  Fluorescent visualization of oxytocin in the hypothalamo-neurohypophysial system.

Authors:  Hirofumi Hashimoto; Takanori Matsuura; Yoichi Ueta
Journal:  Front Neurosci       Date:  2014-07-23       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.